Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on August 24, 2023. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Qiagen EZ2 Extractor

Closed
79154Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

Agency

Department Of Health And Human Services → CDC National Center For Immunization And Respiratory DiseasesView Agency

NAICS

334516 - Analytical Laboratory Instrument ManufacturingView NAICS

Place of Performance

Atlanta, GA, 30341, USA

Set-Aside

NONE

Documents

(1)

SSJ_79154signed.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → CDC National Center For Immunization And Respiratory Diseases
Contacts1 person available
OfficeAtlanta, GA, 30333, USA
Organization / Agency
Department Of Health And Human Services → CDC National Center For Immunization And Respiratory Diseases
View Agency Profile
Office AddressAtlanta, GA, 30333, USA
Contacts
Tiffney Griner-Esslinger

Full Description

Show more
The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price purchase order to Qiagen, LLC for a purchase order for Qiagen EZ2 Extraction Platform to include EZ2 Connect MDx, Connectivity Package B EZ2, EZ2 Connect Installationand Training, and EZ2Connect IQOQ Service. This procurement will satisfy the Agency's requirements because the EZ2 Dx extraction platform is being used to evaluate the performance of the FDA-approved in vitro diagnostic assays in conjunction with extraction on the EZ2 Dx extraction platform. This contract action is for supplies for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b)(SAP) and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within five (5) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at tesslinger@cdc.gov by COB August 28, 2023.